✦ LIBER ✦

Improvement in glycaemic control β-cell function over 2 years with sitagliptin as monotherapy or add-on therapy to metformin in patients with type 2 diabetes

✍ Scribed by Williams-Herman, D.; Seck, T.; Golm, G.; Wang, H.; Johnson, J.; Kaufman, K.D.; Goldstein, B.J.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P0583 SAXAGLIPTIN EITHER AS ADD-ON THERA

✍ Irina Gurieva; Andreas Pfützner; Mikhail Antsiferov; Elsie Allen; Shoba Ravichan 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 71 KB

Efficacy and safety of sitagliptin and m

✍ D. Williams-Herman; J. Johnson; R. Teng; G. Golm; K. D. Kaufman; B. J. Goldstein 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 540 KB

Durability of glycaemic efficacy over 2

✍ Nauck, M. A.; Del Prato, S.; Durán-García, S.; Rohwedder, K.; Langkilde, A. M.; 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 768 KB

Effect of initial combination therapy wi

✍ D. Williams-Herman; L. Xu; R. Teng; G. T. Golm; J. Johnson; M. J. Davies; K. D. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 794 KB

Initial therapy with the fixed-dose comb

✍ J. Wainstein; L. Katz; S. S. Engel; L. Xu; G. T. Golm; S. Hussain; E. A. O’Neill 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 624 KB

Cost–utility analysis of liraglutide com

✍ M. J. Davies; B. D. Chubb; I. C. Smith; W. J. Valentine 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 168 KB